News

New guidelines issued for arthritis drugs

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7307.251/a (Published 04 August 2001) Cite this as: BMJ 2001;323:251
  1. Helen Barratt
  1. BMJ

    Patients with osteoarthritis or rheumatoid arthritis who are at high risk of gastrointestinal complications should have access to COX 2 (cyclo-oxygenase-2) selective inhibitors, according to new guidelines from the National Institute for Clinical Excellence.

    The institute's long awaited report, which applies to patients in England and Wales, classified high risk patients as those …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe